Laurus Synthesis Pvt Ltd receives Form 483 with 5 observations from USFDA

Laurus Synthesis Private Limited (LSPL), a wholly owned subsidiary of Laurus Labs underwent US FDA inspection for the manufacturing facility in Parawada, Anakapalli, near Visakhapatnam, Andhra Pradesh. The inspection was conducted from 4th December, 2023 to 12th December, 2023. We have been issued a Form 483 with five observations and the Company will address the observations within stipulated timelines.

Shares of Laurus Labs Limited was last trading in BSE at Rs. 385.45 as compared to the previous close of Rs. 385.40. The total number of shares traded during the day was 33867 in over 1091 trades.

The stock hit an intraday high of Rs. 388.55 and intraday low of 382.10. The net turnover during the day was Rs. 13084946.00.

Source : Equity Bulls

Keywords

LaurusLabs INE947Q01028 LaurusSynthesis Form483 5Observations